Dr Olena Said
Research Associate / OPEN Trial Manager
Lena joined King's College London in August 2021 as a trial manager for the OPEN Trial (Olanzapine for young PEople with aNorexia nervosa: An open-label feasibility study to test recruitment, treatment acceptance, adherence, safety and outcome measures assessment and patients' experience to prepare for a definitive randomized placebo-controlled trial).
Prior to joining King's Lena has worked as a general practitioner, medical educator and clinical researcher. She has an interest in Eating Disorders, Diabetes and Metabolic Diseases. She obtained an MSc in Eating Disorders and Clinical Nutrition from UCL in 2021 with a research project focusing on the impact of COVID-19 on day care outcomes in Eating Disorders. She also has a PhD in Clinical Pharmacology with research focusing on the impact of GLP-1 analogues on the inflammatory cytokines in overweight patients with Type 2 Diabetes.